Catherine Rhee

896 total citations
25 papers, 571 citations indexed

About

Catherine Rhee is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Catherine Rhee has authored 25 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Catherine Rhee's work include Pluripotent Stem Cells Research (6 papers), Renal and related cancers (5 papers) and CRISPR and Genetic Engineering (4 papers). Catherine Rhee is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), Renal and related cancers (5 papers) and CRISPR and Genetic Engineering (4 papers). Catherine Rhee collaborates with scholars based in United States, Sweden and Australia. Catherine Rhee's co-authors include Jonghwan Kim, Samuel J. Beck, Haley O. Tucker, Bum‐Kyu Lee, David T. Scadden, Lucy LeBlanc, Wenwen Shen, Jiwoon Lee, Matthias Nahrendorf and Michael Freitag and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Blood.

In The Last Decade

Catherine Rhee

24 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Rhee United States 13 375 115 101 90 64 25 571
Chandrashekhar V. Patel United States 16 554 1.5× 51 0.4× 152 1.5× 101 1.1× 42 0.7× 18 773
Tim Pieters Belgium 12 421 1.1× 91 0.8× 52 0.5× 49 0.5× 78 1.2× 26 563
Pradeep Ramalingam United States 12 263 0.7× 186 1.6× 159 1.6× 144 1.6× 48 0.8× 19 535
Akira Harashima Japan 15 243 0.6× 84 0.7× 256 2.5× 79 0.9× 100 1.6× 37 574
Gang Xiao United States 12 227 0.6× 71 0.6× 270 2.7× 58 0.6× 176 2.8× 33 557
Harinad B. Maganti Canada 12 247 0.7× 69 0.6× 31 0.3× 77 0.9× 38 0.6× 25 396
Svitlana Melnik Germany 13 397 1.1× 30 0.3× 71 0.7× 81 0.9× 37 0.6× 20 499
Bernd Lecher Germany 7 128 0.3× 65 0.6× 83 0.8× 28 0.3× 26 0.4× 11 378
Aaron McCarty United States 7 292 0.8× 40 0.3× 338 3.3× 62 0.7× 138 2.2× 7 684
Yvette Y. Yien United States 12 581 1.5× 57 0.5× 30 0.3× 38 0.4× 37 0.6× 18 691

Countries citing papers authored by Catherine Rhee

Since Specialization
Citations

This map shows the geographic impact of Catherine Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Rhee more than expected).

Fields of papers citing papers by Catherine Rhee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Rhee. The network helps show where Catherine Rhee may publish in the future.

Co-authorship network of co-authors of Catherine Rhee

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Rhee. A scholar is included among the top collaborators of Catherine Rhee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Rhee. Catherine Rhee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhavsar, Deepa, Eylem Kulkoyluoglu‐Cotul, Richard W. Tourdot, et al.. (2025). Abstract A040: Resistance to trastuzumab deruxtecan acquired through multifaceted pathway alterations in preclinical models. Molecular Cancer Therapeutics. 24(10_Supplement). A040–A040. 1 indexed citations
2.
Schiroli, Giulia, Vinay K. Kartha, Fabiana M. Duarte, et al.. (2024). Cell of origin epigenetic priming determines susceptibility to Tet2 mutation. Nature Communications. 15(1). 4325–4325. 3 indexed citations
3.
Araujo, Alessandra, Joseph D. Dekker, Kendra Garrison, et al.. (2024). Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice. eLife. 13. 1 indexed citations
4.
Rhee, Catherine, Elizabeth W. Scadden, Lai Ping Wong, et al.. (2023). Limited plasticity of monocyte fate and function associated with epigenetic scripting at the level of progenitors. Blood. 142(7). 658–674. 5 indexed citations
5.
Gustafsson, Karin, Catherine Rhee, Vanessa Frodermann, et al.. (2023). Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody–drug conjugate. Blood Advances. 7(22). 6964–6973. 4 indexed citations
6.
Gastel, Nick van, Jessica B. Spinelli, Azeem Sharda, et al.. (2020). Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance. Cell Metabolism. 32(3). 391–403.e6. 94 indexed citations
7.
Gastel, Nick van, Jessica B. Spinelli, Azeem Sharda, et al.. (2020). Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance. SSRN Electronic Journal. 3 indexed citations
8.
Lee, Bum‐Kyu, Yu Jin Jang, Mijeong Kim, et al.. (2019). Super-enhancer-guided mapping of regulatory networks controlling mouse trophoblast stem cells. Nature Communications. 10(1). 4749–4749. 46 indexed citations
9.
Sévère, Nicolas, Murat Karabacak, Karin Gustafsson, et al.. (2019). Stress-Induced Changes in Bone Marrow Stromal Cell Populations Revealed through Single-Cell Protein Expression Mapping. Cell stem cell. 25(4). 570–583.e7. 85 indexed citations
10.
Gastel, Nick van, Jessica B. Spinelli, Azeem Sharda, et al.. (2019). The Distinctive Metabolic Environment of the Bone Marrow Niche Drives Leukemia Chemoresistance. Blood. 134(Supplement_1). 3725–3725. 1 indexed citations
11.
Ubellacker, Jessalyn M., Ninib Baryawno, Nicolas Sévère, et al.. (2018). Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer. Cancer Research. 78(18). 5300–5314. 23 indexed citations
12.
Beck, Samuel J., Catherine Rhee, Jawon Song, et al.. (2018). Implications of CpG islands on chromosomal architectures and modes of global gene regulation. Nucleic Acids Research. 46(9). 4382–4391. 15 indexed citations
13.
Lee, Bum‐Kyu, et al.. (2017). Fbxl19 recruitment to CpG islands is required for Rnf20-mediated H2B mono-ubiquitination. Nucleic Acids Research. 45(12). 7151–7166. 9 indexed citations
14.
Rhee, Catherine, Bum‐Kyu Lee, Samuel J. Beck, et al.. (2017). Mechanisms of transcription factor-mediated direct reprogramming of mouse embryonic stem cells to trophoblast stem-like cells. Nucleic Acids Research. 45(17). 10103–10114. 20 indexed citations
15.
Lee, Bum‐Kyu, Nadima Uprety, Yu Jin Jang, et al.. (2017). Fosl1 overexpression directly activates trophoblast-specific gene expression programs in embryonic stem cells. Stem Cell Research. 26. 95–102. 16 indexed citations
16.
Kim, Peter G., Matthew C. Canver, Catherine Rhee, et al.. (2016). Interferon-α signaling promotes embryonic HSC maturation. Blood. 128(2). 204–216. 36 indexed citations
17.
Rhee, Catherine, Melissa A. Edwards, June Harris, et al.. (2016). ARID3A is required for mammalian placenta development. Developmental Biology. 422(2). 83–91. 24 indexed citations
18.
Lee, Bum-Kyu, Wenwen Shen, Jiwoon Lee, et al.. (2015). Tgif1 Counterbalances the Activity of Core Pluripotency Factors in Mouse Embryonic Stem Cells. Cell Reports. 13(1). 52–60. 22 indexed citations
19.
Rhee, Catherine, He Li, Cathrine A. Miner, et al.. (2014). Bright/Arid3A Acts as a Barrier to Somatic Cell Reprogramming through Direct Regulation of Oct4, Sox2, and Nanog. Stem Cell Reports. 2(1). 26–35. 41 indexed citations
20.
Beck, Samuel J., Bum-Kyu Lee, Catherine Rhee, et al.. (2014). CpG island-mediated global gene regulatory modes in mouse embryonic stem cells. Nature Communications. 5(1). 5490–5490. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chandrashekhar V. Patel Breakdown of academic impact, for papers by Tim Pieters Breakdown of academic impact, for papers by Pradeep Ramalingam Breakdown of academic impact, for papers by Akira Harashima Breakdown of academic impact, for papers by Gang Xiao Breakdown of academic impact, for papers by Harinad B. Maganti Breakdown of academic impact, for papers by Svitlana Melnik Breakdown of academic impact, for papers by Bernd Lecher Breakdown of academic impact, for papers by Aaron McCarty Breakdown of academic impact, for papers by Yvette Y. Yien
Rankless by CCL
2026